KESFLOX

This brand name is authorized in Nigeria.

Active ingredients

The drug KESFLOX contains one active pharmaceutical ingredient (API):

1	Ofloxacin UNII A4P49JAZ9H - OFLOXACIN
	Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination.
	Read more about Ofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7260	Tablet	Kesflox Tablets TAB 400 mg 1 x 10's (in PVC-Alu pack)	Tablet KESFLOX TABLETS B4-7260 KESFLOX TABLETS Ofloxacin USP 400mg. Excipients: Microcrystalline Cellulose BP, Sodium Starch Glycolate BP, Maize Starch BP, Purified Water BP, Colloidal Anhydrous Silica BP, Purified Talc BP, Magnesium Stearate BP Titanium Dioxide Ready Film Coat HIS, Isopropyl Alcohol BP, Dichloromethane BP Prescription Only Medicine (POM) KESSINGTON GLOBAL SYNERGY LTD, GOVERNORS WAY MAPLE WOOD ESTATE OKO-OBA LAGOS AGEGE LAGOS Ratnamani Healthcare Pvt. Ltd., SURVEY NO. 750/1, AHMEDABAD-MEHSANA HIGHWAY, VII: INDRAD 382721, INDIA, India 2/23/2023 2/22/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA01	Ofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7260